This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nanjundan, M. Articles by Mills, G. B. Search for Related Content PubMed PubMed Citation Articles by Nanjundan, M. Articles by Mills, G. B.

Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer

Departments of ¹ Molecular Therapeutics, ² Pathology, and ³ Gynecologic Oncology, M. D. Anderson Cancer Center, University of Texas, Houston, Texas; ⁴ Department of Laboratory Medicine, University of California, San Francisco, and the Lawrence Berkeley National Laboratory, Berkeley, California; ⁵ Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California; and ⁶ New York University, New York, New York

Requests for reprints: Meera Nanjundan, M. D. Anderson Cancer Center, Department of Molecular Therapeutics, University of Texas, 1515 Holcombe Boulevard, Box 0950, Houston, TX 77054. Phone: 713-563-4225; Fax: 713-563-4235; E-mail: mnanjund{at}mdanderson.org.

Increased copy number involving chromosome 3q26 is a frequent and early event in cancers of the ovary, lung, head and neck, cervix, and BRCA1 positive and basal breast cancers. The p110 catalytic subunit of phosphoinositide-3-kinase (PI3KCA) and protein kinase C (PKC) have previously been shown as functionally deregulated by 3q copy number increase. High-resolution array comparative genomic hybridization of 235 high-grade serous epithelial ovarian cancers using contiguous bacterial artificial chromosomes across 3q26 delineated an 2 Mb–wide region at 3q26.2 encompassing PDCD10 to MYNN (chr3:168722613-170908630). Ecotropic viral integration site-1 (EVI1) and myelodysplastic syndrome 1 (MDS1) are located at the center of this region, and their DNA copy number increases are associated with at least 5-fold increased RNA transcript levels in 83% and 98% of advanced ovarian cancers, respectively. Moreover, MDS1/EVI1 and EVI1 protein levels are increased in ovarian cancers and cancer cell lines. EVI1 and MDS1/EVI1 gene products increased cell proliferation, migration, and decreased transforming growth factor-ß–mediated plasminogen activator inhibitor-1 promoter activity in ovarian epithelial cells. Intriguingly, the increases in EVI1 DNA copy number and MDS1/EVI1 transcripts are associated with improved patient outcomes, whereas EVI1 transcript levels are associated with a poor patient survival. Thus, the favorable patient prognosis associated with increased DNA copy number seems to be as a result of high-level expression of the fusion transcript MDS1/EVI1. Collectively, these studies suggest that MDS1/EVI1 and EVI1, previously implicated in acute myelogenous leukemia, contribute to the pathophysiology of epithelial ovarian cancer. [Cancer Res 2007;67(7):3074–84]

This article has been cited by other articles:

				T. A. Konrad, A. Karger, H. Hackl, I. Schwarzinger, I. Herbacek, and R. Wieser Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes J. Leukoc. Biol., October 1, 2009; 86(4): 813 - 822. [Abstract] [Full Text] [PDF]

				D. Etemadmoghadam, A. deFazio, R. Beroukhim, C. Mermel, J. George, G. Getz, R. Tothill, A. Okamoto, M. B. Raeder, AOCS Study Group, et al. Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas Clin. Cancer Res., February 15, 2009; 15(4): 1417 - 1427. [Abstract] [Full Text] [PDF]

				Z.-B. Ding, Y.-H. Shi, J. Zhou, S.-J. Qiu, Y. Xu, Z. Dai, G.-M. Shi, X.-Y. Wang, A.-W. Ke, B. Wu, et al. Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma Cancer Res., November 15, 2008; 68(22): 9167 - 9175. [Abstract] [Full Text] [PDF]

				J. Kendall, Q. Liu, A. Bakleh, A. Krasnitz, K. C. Q. Nguyen, B. Lakshmi, W. L. Gerald, S. Powers, and D. Mu Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer PNAS, October 16, 2007; 104(42): 16663 - 16668. [Abstract] [Full Text] [PDF]